How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology, and Vaccines

Published on: 

Many CDMOs outsource their nanoparticle supply chain, but in house manufacturing of nanoparticles at CDMOs is anticipated to create new market opportunities.